Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in ItalyPaolo Bidoli, Angelo Delmonte, Cristina Noberasco et al.|Annals of Oncology|2016Cited by 19
P3.02c-094 Italian Nivolumab Advanced Squamous NSCLC Expanded Access Program: Efficacy and Safety in Patients with Brain MetastasesDiego Cortinovis, Francesco Cognetti, Angelo Delmonte et al.|Journal of Thoracic Oncology|2017Cited by 8